[HTML][HTML] Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis

D De Ruysscher, B Lueza, C Le Péchoux… - Annals of …, 2016 - Elsevier
Background Chemotherapy (CT) combined with radiotherapy is the standard treatment of
'limited-stage'small-cell lung cancer. However, controversy persists over the optimal timing …

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis

D De Ruysscher, B Lueza… - Annals of oncology …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Chemotherapy (CT) combined with radiotherapy is the standard treatment
of'limited-stage'small-cell lung cancer. However, controversy persists over the optimal timing …

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis

D de Ruysscher, B Lueza, C Le Péchoux… - Annals of …, 2016 - inria.hal.science
Background Chemotherapy combined with radiotherapy is the standard treatment of “limited-
stage” small-cell lung cancer. However, controversy persists over the optimal timing of …

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis

D de Ruysscher, B Lueza, C Le Péchoux… - Annals of …, 2016 - hal.science
Background Chemotherapy combined with radiotherapy is the standard treatment of “limited-
stage” small-cell lung cancer. However, controversy persists over the optimal timing of …

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis

D de Ruysscher, B Lueza, C Le Péchoux… - Annals of …, 2016 - hal.uvsq.fr
Background Chemotherapy combined with radiotherapy is the standard treatment of “limited-
stage” small-cell lung cancer. However, controversy persists over the optimal timing of …

[HTML][HTML] Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis

D De Ruysscher, B Lueza, C Le Péchoux… - Annals of …, 2016 - ncbi.nlm.nih.gov
Background: Chemotherapy (CT) combined with radiotherapy is the standard treatment of
'limited-stage'small-cell lung cancer. However, controversy persists over the optimal timing …

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis

D De Ruysscher, B Lueza, C Le Péchoux… - Annals of …, 2016 - annalsofoncology.org
Background Chemotherapy (CT) combined with radiotherapy is the standard treatment of
'limited-stage'small-cell lung cancer. However, controversy persists over the optimal timing …

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis (aEuro)

D De Ruysscher, B Lueza… - Annals of …, 2016 - cris.maastrichtuniversity.nl
The optimal timing and sequencing of thoracic radiotherapy and chemotherapy, which is the
standard treatment of'limited-stage'small-cell lung cancer, has fuelled debate for many …

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: Usefulness of the individual patient data meta-analysis

RTT-SCLC Collaborative Group - Annals of …, 2016 - utsouthwestern.elsevierpure.com
Background: Chemotherapy (CT) combined with radiotherapy is the standard treatment
of'limited-stage'small-cell lung cancer. However, controversy persists over the optimal timing …

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis

D De Ruysscher, B Lueza, C Le Péchoux… - Annals of …, 2016 - discovery.ucl.ac.uk
Background: Chemotherapy (CT) combined with radiotherapy is the standard treatment of
'limited-stage'small-cell lung cancer. However, controversy persists over the optimal timing …